IP finance

RSS

Where money issues meet intellectual property rights

thumbnail

New Trump Administration U.S. FDA Working Group on Importation of Pharmaceuticals

thumbnail

US Department of Energy Online Laboratory Partnering Service

thumbnail

Trump Administration FDA Moves to Speed Up Biosimilar Process in United States

thumbnail

Professor Nimmer on Revised Article 9 and IP Financing

thumbnail

Cellular inventions trigger avalanche of activities among companies

thumbnail

Making Patents Great Again: U.S. Supreme Court Allows Foreign Lost Profits for Infringement Under 271(f)(2)

thumbnail

Disincentivizing the Use of IPRs and PGRs Against Pharmaceutical and Biologic Patents

thumbnail

Judges Lourie and Newman of the Federal Circuit Critique Alice/Mayo and Myriad

thumbnail

Independent judiciary requires reliability and factual credibility in economic analysis

thumbnail

ESPN+ and the streaming of sports events--will it complement or cannibalize?

thumbnail

FDA Attempts to Shame Pharmacuetical and Biotechnology Companies

thumbnail

Gender Diversity in IP and Technology Policy: A New Resource and Way to get Noticed

thumbnail

Solutions in Search of a Problem: The Trademark Register Clogged?

thumbnail

Trump Administration Releases Annual IP Report to Congress

thumbnail

Unreasonably-low royalties in top-down FRAND-rate determinations for TCL v. Ericsson

For more from “IP finance” please visit ipfinance.blogspot.com